145 related articles for article (PubMed ID: 18503891)
1. HMG-CoA reductase inhibitors deplete circulating classical and non-classical monocytes following human heart transplantation.
Fildes JE; Shaw SM; Mitsidou A; Rogacev K; Leonard CT; Williams SG; Yonan N
Transpl Immunol; 2008 May; 19(2):152-7. PubMed ID: 18503891
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Teupser D; Bruegel M; Stein O; Stein Y; Thiery J
Biochem Biophys Res Commun; 2001 Dec; 289(4):838-44. PubMed ID: 11735122
[TBL] [Abstract][Full Text] [Related]
3. Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population.
Coen PM; Flynn MG; Markofski MM; Pence BD; Hannemann RE
Metabolism; 2010 Dec; 59(12):1775-83. PubMed ID: 20580035
[TBL] [Abstract][Full Text] [Related]
4. Ezetimibe and atorvastatin both immunoregulate CD4+ T cells from cardiac transplant recipients invitro.
Shaw SM; Najam O; Khan U; Yonan N; Williams SG; Fildes JE
Transpl Immunol; 2009 Jul; 21(3):179-82. PubMed ID: 19332119
[TBL] [Abstract][Full Text] [Related]
5. In vivo extravasated human monocytes have an altered expression of CD16, HLA-DR, CD86, CD36 and CX(3)CR1.
Paulsson JM; Held C; Jacobson SH; Lundahl J
Scand J Immunol; 2009 Oct; 70(4):368-76. PubMed ID: 19751271
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes.
Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Weitz-Schmidt G; Nishibori M
J Leukoc Biol; 2005 Mar; 77(3):400-7. PubMed ID: 15618295
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation.
Aliabadi AZ; Mahr S; Dunkler D; Grömmer M; Zimpfer D; Wolner E; Grimm M; Zuckermann AO
Transplantation; 2008 Dec; 86(12):1771-6. PubMed ID: 19104420
[TBL] [Abstract][Full Text] [Related]
8. Integrin expression on monocytes and lymphocytes in unstable angina short term effects of atorvastatin.
Dobreanu M; Dobreanu D; Fodor A; Bacarea A
Rom J Intern Med; 2007; 45(2):193-9. PubMed ID: 18333374
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
Crespo-Leiro MG; Paniagua MJ; Marzoa R; Grille Z; Naya C; Flores X; Rodriguez JA; Mosquera V; Franco R; Castro-Beiras A
Transplant Proc; 2008 Nov; 40(9):3060-2. PubMed ID: 19010194
[TBL] [Abstract][Full Text] [Related]
10. Monocyte subtypes predict clinical course and prognosis in human stroke.
Urra X; Villamor N; Amaro S; Gómez-Choco M; Obach V; Oleaga L; Planas AM; Chamorro A
J Cereb Blood Flow Metab; 2009 May; 29(5):994-1002. PubMed ID: 19293821
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of autoreactive T-cells by HMG CoA reductase inhibitors.
Brumeanu TD; Goldstein R; Casares S
Clin Immunol; 2006 Apr; 119(1):1-12. PubMed ID: 16386956
[TBL] [Abstract][Full Text] [Related]
12. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
[TBL] [Abstract][Full Text] [Related]
13. Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction.
Takahashi HK; Iwagaki H; Yagi T; Kanke T; Liu K; Yoshino T; Tanaka N; Nishibori M
Clin Immunol; 2007 Jun; 123(3):324-32. PubMed ID: 17482516
[TBL] [Abstract][Full Text] [Related]
14. Statins enhance circulating vitamin E.
Cangemi R; Loffredo L; Carnevale R; Pignatelli P; Violi F
Int J Cardiol; 2008 Jan; 123(2):172-4. PubMed ID: 17306387
[TBL] [Abstract][Full Text] [Related]
15. Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study).
Tung P; Wiviott SD; Cannon CP; Murphy SA; McCabe CH; Gibson CM
Am J Cardiol; 2009 Apr; 103(8):1056-60. PubMed ID: 19361589
[TBL] [Abstract][Full Text] [Related]
16. Class effects of statins in elderly patients with congestive heart failure: a population-based analysis.
Rinfret S; Behlouli H; Eisenberg MJ; Humphries K; Tu JV; Pilote L
Am Heart J; 2008 Feb; 155(2):316-23. PubMed ID: 18215603
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobic but not hydrophilic statins enhance phagocytosis and decrease apoptosis of human peripheral blood cells in vitro.
Salman H; Bergman M; Djaldetti M; Bessler H
Biomed Pharmacother; 2008 Jan; 62(1):41-5. PubMed ID: 17768028
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans.
Simpson RJ; McFarlin BK; McSporran C; Spielmann G; ó Hartaigh B; Guy K
Brain Behav Immun; 2009 Feb; 23(2):232-9. PubMed ID: 18930806
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).
Brilakis ES; de Lemos JA; Cannon CP; Wiviott SD; Murphy SA; Morrow DA; Sabatine MS; Banerjee S; Blazing MA; Califf RM; Braunwald E
Am J Cardiol; 2008 Sep; 102(5):552-8. PubMed ID: 18721511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]